Tapentadol MSN 100 mg prolonged-release tablets

Licence status
Authorised: 06/03/2026
Active substances
Tapentadol tartrate
Dosage Form
Prolonged-release tablet
Licence number
PA23250/009/003
Licence holder
MSN Labs Europe Limited

Product documents

Licence information

ATC code
N02AX06 tapentadol
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
06/03/2026